Rosemary metabolite carnosic acid opens K v 1.1 via its voltage sensor and corrects K v 1.1‐linked episodic ataxia in mice
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Rían W Manville und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioelectricity Laboratory, Dept. of Physiology and Biophysics, School of Medicine, University of California, Irvine, California, USA. Hauptthemen laut MEDLINE: Abietanes, Ataxia, Kv1.1 Potassium Channel, Rosmarinus. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NCCIH NIH HHS.
Abstract (Originalsprache)
Background and Purpose Episodic ataxia type 1 (EA1) is an autosomal dominant neurological disorder caused primarily by loss‐of‐function mutations in the voltage‐gated potassium channel K v 1.1 ( KCNA1 ). Small molecules that restore K v 1.1 activity hold promise as targeted therapies for EA1, yet current pharmacological strategies remain limited. Experimental Approach Two electrode voltage‐clamp electrophysiology and the Xenopus laevis oocyte expression system were used to study effects of carnosic acid, a phenolic diterpene from Salvia rosmarinus (rosemary) leaf extract on K v 1.1‐linked EA1 mutant channels. We assessed ataxia therapeutic efficacy by comparing performance of Kcna1 +/+ and Kcna1 E283K/+ mice, a model of human EA1, on a balance beam under isoproterenol challenge in the absence or presence of 0.3‐mg·kg −1 carnosic acid. Key Results Rosemary leaf extract and rosemary metabolite carnosic acid are efficacious K v 1.1 openers. Carnosic acid fully or partially corrects heterozygous, heteromeric K v 1.1 EA1 mutant channel activity in vitro and restores normal function in K v 1.1 E283K/+ mice at 0.3 mg·kg −1 . Experimental validation of unbiased in silico docking reveals carnosic acid occupies a binding pocket between the S1 and S4 helices of the voltage‐sensing domain (VSD) of K v 1.1. Finally, we determined the chemical properties that endow carnosic acid with the ability to open K v 1.1 channels. Conclusions and Implications Our findings uncover a K v 1.1 opener with the potential to reverse EA1 and other K v 1.1‐linked disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioelectricity Laboratory, Dept. of Physiology and Biophysics, School of Medicine, University of California, Irvine, California, USA.
- Departments of Physiology & Biophysics, Pediatrics, and Pharmaceutical Sciences, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, California, USA.
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
- NCCIH NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Heart, Lung, and Blood Institute
- National Center for Complementary and Integrative Health
Zitieren
APA
Manville, R. W., Yoshimura, R. F., Nguyen, H. A., Zhao, R., Hogenkamp, D. J., Goldstein, S. A. N., & Abbott, G. W. (2026). Rosemary metabolite carnosic acid opens K v 1.1 via its voltage sensor and corrects K v 1.1‐linked episodic ataxia in mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.70578
Vancouver
Manville RW, Yoshimura RF, Nguyen HA, Zhao R, Hogenkamp DJ, Goldstein SAN, et al. Rosemary metabolite carnosic acid opens K v 1.1 via its voltage sensor and corrects K v 1.1‐linked episodic ataxia in mice. British Journal of Pharmacology. 2026. doi:10.1111/bph.70578
BibTeX
@article{Manville2026,
author = {Manville, Rían W and Yoshimura, Ryan F and Nguyen, Hanh A and Zhao, Ruiming and Hogenkamp, Derk J and Goldstein, Steve A N and Abbott, Geoffrey W},
title = {Rosemary metabolite carnosic acid opens K v 1.1 via its voltage sensor and corrects K v 1.1‐linked episodic ataxia in mice},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70578}
}
EUVIMED